Degron Therapeutics Secures $20M Series A+ for Molecular Glue Drug Development
China-based Degron Therapeutics, a specialist in molecular glue-based drugs, has reportedly raised over USD 20...
Deals
Sichuan Biokin Re-submits IPO Application to Hong Kong Stock Exchange
Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506) has announced that it has resubmitted its application...
Lepu Biopharma Licenses Potential Best-in-Class ADC MRG007 to ArriVent
Lepu Biopharma Co., Ltd (HKG: 2157) has announced an exclusive licensing agreement with ArriVent BioPharma,...
Keymed and InnoCare Announce Licensing Deal for CD20xCD3 Bispecific Antibody with Prolium
China-based Keymed Biosciences Inc. (HKG: 2162) and InnoCare Pharma (HKG: 9969, SHA: 688428) have jointly...
Junshi Biosciences Licenses Toripalimab to LEO Pharma for EU and UK Markets
China-based Shanghai Junshi Biosciences Co., Ltd (HKG: 1877, SHA: 688180) has announced a licensing agreement...
Danaher Partners with Huashan Hospital to Develop Alzheimer’s Diagnostic Solutions
US-based science and tech services giant Danaher Corporation (NYSE: DHR) has announced a partnership between...
Takeda to Establish China Innovation Center in Chengdu, Focusing on Digital Health
Japan-headquartered Takeda (NYSE: TAK, TYO: 4502) has announced plans to establish the Takeda China Innovation...
NAMSA to Acquire WuXi AppTec’s US Medical Device Testing Business
US-based medical device contract research organization (CRO) NAMSA is set to acquire the medical device...
Xinzeyuan Medical Raises Series B+ Funding for Surgical Supply Chain
Xinzeyuan Medical Technology Co., Ltd, a minimally invasive surgical supply chain platform enterprise based in...
IVIEW Therapeutics Secures Series A++ Funding for Ophthalmology Pipeline
IVIEW Therapeutics Inc., an ophthalmology biotech operating out of the US and China, has reportedly...
Daiichi Sankyo Acquires Gatipotuzumab IP Rights for $132.5M
Japan-based Daiichi Sankyo Company, Ltd (TYO: 4568) has announced an investment of USD 132.5 million...
a16z Bio + Health Launches Biotech Ecosystem Venture Fund
Andreessen Horowitz (a16z) Bio + Health has announced the establishment of the Biotech Ecosystem Venture...
Fujian Haixi Pharmaceuticals Files for Hong Kong IPO
China-based Fujian Haixi Pharmaceuticals Co., Ltd., a commercial-stage innovative pharmaceutical company, has made an initial...
Servier and Google Cloud Extend Partnership to Advance AI in Drug Development
France-based Servier Group and US technology firm Google Cloud have announced an expansion to their...
Cathay Biotech Plans $901M Private Placement to Boost Bio-Based Materials
Shanghai-based Cathay Biotech Inc. (SHA: 688065) has announced plans to raise RMB 6.6 billion (USD...
Simcere Licenses Fermion’s AI-Enabled Painkiller FZ002-037
China-based Simcere Pharmaceutical Group Limited (HKG: 2096) has announced a licensing agreement with compatriot firm...
Bio-Thera Solutions Licenses BAT2206 to World Medicine for Turkey
On January 16, Bio-Thera Solutions Ltd (SHA: 688177), a science – driven innovative global biopharmaceutical...
GE Healthcare and Sutter Health Form $1B Care Alliance
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) has formed...
Biogen Proposes to Acquire Sage Therapeutics for $469M
US-based Sage Therapeutics, Inc. (NASDAQ: SAGE) has announced that it received an unsolicited, nonbinding proposal...
Medtronic Secures Exclusive Distribution Rights for Contego’s Neuroguard and Excipio
US-Irish firm Medtronic (NYSE: MDT) has entered into an exclusive distribution agreement with Contego Medical,...